Myocardial Infarction clinical trials
34 active trials name this condition. Describe your situation to see which ones you may be eligible for.
By location
- Examination of the Impact of CalmiGo's Stress Management Device on Vascular Heath and Cardiovascular Disease Risk.
- TeleheartCR vs. Clinic-Based Cardiac Rehabilitation After Acute Coronary Syndrome
- Physiology-guided vs Angiography-guided Non-culprit Lesion Complete Revascularization for Acute MI & Multivessel Disease
- Focused Orticumab Research for Treating Inflammation in Coronary Arteries
- Multi-Center Study of Clinical and Inflammatory Outcomes in Intensive Cardiac Rehabilitation and Traditional Cardiac Rehabilitation Programs
- Improving Cardiac Rehabilitation Exercise Using Target Heart Rate Trial
- MCNAIR Study: coMparative effeCtiveness of iN-person and teleheAlth cardIac Rehabilitation
- Designing and Assessing a Women Only Cardiac Rehabilitation (CARE) Program
- Smoking Cessation Pharmacotherapy-Nurse Practitioner Led Tobacco Treatment Team Study
- Programmed Ventricular Stimulation to Risk Stratify for Early Cardioverter-Defibrillator (ICD) Implantation to Prevent Tachyarrhythmias Following Acute Myocardial Infarction (PROTECT-ICD)
- Reducing Blood Pressure in Patients With High Cardiovascular Risk
- Smartphone Twelve-Lead ECG Utility In ST-Elevation Myocardial Infarction II
- Diffusion MRI in Heart Failure
- Heart Attack Research Program: Platelet Sub-Study (HARP)
- Integration of Telemedicine and Home-Based Cardiac Rehabilitation: Feasibility, Efficacy, and Adherence
- Study of Circulating Monocytes in Patients With Ischemic Vascular Disease
- Inova Cardiogenic Shock Registry (INOVA SHOCK)
- Circulating Markers for Ischemic Heart Disease
- Technical and Translational Development of Cardiovascular Magnetic Resonance (CMR) Imaging
- AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor
- End Diagnostic Overshadowing:Addressing Ableism in Diagnoses
- Influence of Pulse Electromagnetic Field Therapy on Myocardial Ischemia
- Pharmacy-led Transitions of Care Intervention to Improve Medication Adherence
- Multimodality Cardiovascular Imaging for the Translation of Therapies for Vascular Activation After MI
- Cardiac Radioablation for VT
- Clinical Evaluation of Radiation Reduction for Optimized Safety
- A Study of Microcirculatory Function in Type 2 Myocardial Infarction (T2MI)
- Health Coaching for Patients With Cardiovascular Disease
- Voice Analysis Technology to Detect and Manage Depression and Anxiety in Cardiac Rehabilitation
- Ultralow Dose PET Imaging of 18F-flurpiridaz
- COR-INSIGHT: Optimizing Cardiovascular and Cardiopulmonary Outcomes with AI-Driven Multiplexed Indications Using COR ECG Wearable
- The Heart Health After Cardiac Treatment Study
- GSI Cardiac on Revolution Apex - US
- FDG an Myocardial Infarction: The PIAF Trial
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Myocardial Infarction” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.